ArticleFrontiers in pharmacology2023

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years.

Julian Berges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.